A review of 25 years of the social interaction test.
The social interaction test of anxiety was developed 25 years ago to provide an ethologically based test that was sensitive to both anxiolytic and anxiogenic effects. It is sensitive to a number of environmental and physiological factors that can affect anxiety. It has detected anxiogenic effects of peptides such as corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH), and anxiolytic effects of neuropeptide Y and substance P receptor antagonists. It has successfully identified neuropharmacological sites of action of anxiogenic compounds and drug withdrawal. Effects of compounds acting on the gamma-aminobutyric acid (GABA) and 5-hydroxytryptamine (5-HT) systems have been extensively investigated after both systemic administration and microinjection into specific brain regions. The use of this test has, thus, played a crucial role in unravelling the neural basis of anxiety. It is hoped that in the next 25 years, the test will play a crucial role in determining the genetic basis of anxiety disorders.
File
Sandra E
SE
Psychopharmacology Research Unit, Centre for Neuroscience, King's College London, Guy's Campus, UK.
Seth
Pallab
P
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology; D001007:Anxiety / Q000139:chemically induced / Q000378:metabolism / Q000523:psychology*; D001522:Behavior, Animal / Q000187:drug effects; D001921:Brain / Q000503:physiopathology; D004195:Disease Models, Animal; D004777:Environment; D009479:Neuropeptides / Q000378:metabolism / Q000494:pharmacology; D018377:Neurotransmitter Agents / Q000378:metabolism* / Q000494:pharmacology; D012919:Social Behavior; D013375:Substance Withdrawal Syndrome / Q000209:etiology / Q000523:psychology
D014151:Anti-Anxiety Agents; D009479:Neuropeptides; D018377:Neurotransmitter Agents